Purchase Order 1240BG22P0039

Award Date 6/23/22
Potential Completion Date 9/5/25
Potential Value $10K
Contracting Federal Agency
Forest Service
Ultimate Awardee
Macrogen, Inc.
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Moscow, ID 83843, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Psomagen Inc., a subsidiary of Macrogen, Inc., is for DNA sequencing and genetic marker analysis services to support multi-year research by the U.S. Forest Service Research Service Rocky Mountain Research Station, a civilian agency. The $10,000 firm-fixed-price contract, awarded on August 12, 2020, does not have a set-aside designation. Psomagen Inc. has a history of providing genomic services to various government agencies, including the National Institutes of...
This federal contract award, valued at $9,970.00, was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Psomagen Inc., a subsidiary of Macrogen, Inc. The contract is for the provision of genomic and molecular biology services, including whole genome sequencing, RNA sequencing, and epigenome sequencing, to support research initiatives. Psomagen Inc. has established itself as a key provider of genomic services to various federal agencies, particularly within...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Psomagen Inc., a subsidiary of Macrogen, Inc. The $10,000.00 firm fixed-price purchase order is for DNA sequencing services. The contract has no set-aside designation. Psomagen Inc. is a provider of genomic and molecular biology services, including whole genome sequencing, RNA sequencing, and epigenome sequencing, that supports...
This is a firm fixed-price delivery order awarded to Psomagen Inc., a for-profit manufacturer of goods, for Sanger sequencing services. The contract, valued at $10,000.00, was awarded by the U.S. Department of Agriculture's (USDA) Plant Protection and Quarantine division on March 10, 2025, with a completion date of January 13, 2026. Psomagen Inc. is a subsidiary of Macrogen, Inc. and provides genomic and molecular biology services to federal agencies. The company has established itself as a...
This federal contract award, with a ceiling value of $27,600, was issued by the National Institute of Mental Health (NIMHD) to Psomagen Inc., a subsidiary of Macrogen, Inc. The contract is for bioinformatics services related to RNA/DNA sequencing. Psomagen, a small business, has a history of providing genomic services to various federal agencies, including the National Institutes of Health (NIH), U.S. Department of Agriculture (USDA), and Smithsonian Institution, through both contract and...
This federal contract award, valued at $118,650.00, was made by the National Institute of Child Health and Human Development to Psomagen Inc., a subsidiary of Macrogen, Inc. The contract is for sequencing services to support whole exome sequencing research. The award did not have a set-aside designation. Psomagen Inc. is a provider of advanced genomic and molecular biology services to federal agencies, including the National Institutes of Health, U.S. Department of Agriculture, and Smithsonian...
This is a firm fixed-price purchase order awarded by the U.S. Department of Agriculture's Agricultural Research Service (USDA-ARS) to Psomagen Inc., a subsidiary of Macrogen, Inc. The $29,577.60 contract is for RNA sequencing services to support wheat research, including sample QC, library prep, sequencing, and data delivery. The award is a small business set-aside contract under NAICS code 541714 (Research and Development in Biotechnology). Psomagen, a CLIA-certified and CAP-accredited provider...
This is a firm-fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Psomagen Inc., a wholly-owned subsidiary of Macrogen, Inc. The contract ceiling value is $9,999.30 and it is for DNA sequencing services. The contract is not set aside for any specific business category. Psomagen Inc. is a leading provider of genomic and molecular biology services to federal agencies, including the National Institutes of Health (NIH), U.S. Department...
This is a federal purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH), to Psomagen Inc., a subsidiary of Macrogen, Inc. The contract, valued at $4,942.00, is for DNA sequencing services. It is not a set-aside contract. The contract supports NIAID's research efforts, potentially including work on neurodegenerative diseases, cancer, and infectious diseases. Psomagen has previously received...
This federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Psomagen Inc., a subsidiary of Macrogen, Inc. The $11,381 firm-fixed-price purchase order contract was awarded on July 5, 2011, with a completion date of July 4, 2012. The contract did not have a set-aside designation. Psomagen Inc. is a multiomics contract laboratory that provides a range of genomic and molecular biology services,...

This federal contract award, valued at $10,000.00, was issued by the United States Department of Agriculture (USDA) Forest Service Research Service Rocky Mountain Research Station to Psomagen Inc., a subsidiary of Macrogen, Inc. The contract is for DNA sequencing services with a completion date of September 5, 2025.

Psomagen Inc. is a provider of genomic and molecular biology services to various federal agencies, including the National Institutes of Health (NIH) and the USDA. The company has expertise in advanced sequencing technologies and data analysis, and has supported research in areas such as neurodegenerative diseases, cancer, infectious diseases, and agricultural genetics. This contract award does not have a set-aside designation. Additionally, Psomagen Inc. holds two significant Indefinite Delivery Vehicles (IDVs) with the USDA and the NIH National Heart, Lung and Blood Institute, valued at $80,000 and $500 million respectively, to provide specialized sequencing services and large-scale omics data analysis and management.

Generated 4/13/25, 12:46 AM